rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-5-24
|
pubmed:abstractText |
For recipients of haploidentically mismatched stem cell allografts, T-cell depletion is mandatory to prevent lethal graft-vs-host disease (GVHD). Prevention of GVHD can be accomplished by negative selection of T cells or positive selection of stem cells. Recently, a new method for positive selection of stem cells was introduced using monoclonal antibodies against CD133 antigen. We report five cases of successful application of immunomagnetic separation of CD133+ stem cells for haploidentically mismatched allogeneic stem cell transplantation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0301-472X
|
pubmed:author |
pubmed-author:AckersteinAlizaA,
pubmed-author:AmarAvrahamA,
pubmed-author:BitanMenachemM,
pubmed-author:EladSharonS,
pubmed-author:FibachEitanE,
pubmed-author:IsraelShoshS,
pubmed-author:MironSvetlanaS,
pubmed-author:OrReuvenR,
pubmed-author:ResnickIgor BIB,
pubmed-author:SamuelSimchaS,
pubmed-author:ShapiraMichael YMY,
pubmed-author:SlavinShimonS,
pubmed-author:ZilbermanIrinaI
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
713-8
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15911096-Adolescent,
pubmed-meshheading:15911096-Adult,
pubmed-meshheading:15911096-Antigens, CD,
pubmed-meshheading:15911096-Child,
pubmed-meshheading:15911096-Female,
pubmed-meshheading:15911096-Glycoproteins,
pubmed-meshheading:15911096-Graft vs Host Disease,
pubmed-meshheading:15911096-Haplotypes,
pubmed-meshheading:15911096-Humans,
pubmed-meshheading:15911096-Male,
pubmed-meshheading:15911096-Middle Aged,
pubmed-meshheading:15911096-Peptides,
pubmed-meshheading:15911096-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:15911096-Transplantation, Homologous
|
pubmed:year |
2005
|
pubmed:articleTitle |
Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells.
|
pubmed:affiliation |
Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem 91120, Israel.
|
pubmed:publicationType |
Journal Article
|